Novartis AG said on Thursday it would sell the dermatology and generic US oral solids portfolios of Sandoz US to Aurobindo Pharma Ltd for $900 million, as the Swiss drug maker looks to focus on higher...
from NDTV Profit - Latest https://ift.tt/2wOxNml
from NDTV Profit - Latest https://ift.tt/2wOxNml
Novartis Sells Parts Of Sandoz US To Aurobindo Pharma For $900 Million
![Novartis Sells Parts Of Sandoz US To Aurobindo Pharma For $900 Million]()
Reviewed by placements page
on
September 05, 2018
Rating:
No comments: